Nath Bio-Genes (India) Limited — Board Meeting, 29-04-2025: Outcome of Board Meeting

Nath Bio-Genes (India) Limited has announced a board meeting outcome highlighting its consolidated financial results. Revenue from operations reached ₹36,490.82 cr, with a net profit of ₹3,859.98 cr. The board proposed a dividend of ₹2 per equity share for the 2024-25 financial year, pending shareholder approval at the upcoming AGM. There has been a change in the board, with Ms. Ashu Jain resigning as an Independent Director and Ms. Shipra Atul Agrawal appointed to take her place. Additionally, Mr. Vadla Nagabhushanam and Mr. Madhukar Deshpande have been reappointed as Independent Directors.